Literature DB >> 3040616

An immunogenetic analysis of resistance to herpes simplex virus retinitis in inbred strains of mice.

J S Pepose, J A Whittum-Hudson.   

Abstract

Specific inbred strains of mice have been shown to vary considerably in their resistance and susceptibility to herpes simplex virus (HSV) infection. We injected 2 X 10(5) plaque forming units (PFU) of the KOS strain of HSV-1 intracamerally into one eye of BALB/c, C57Bl/6, and F1 (BALB/c X C57Bl/6) mice. HSV-1 antigens were localized in frozen sections of enucleated eyes at 10 to 14 days post-inoculation. Injected eyes of BALB/c mice showed an anterior uveitis with HSV-1 antigens in the anterior segment and an intact retina free of HSV antigens. The retina of the contralateral uninjected eye was necrotic and contained HSV-1 antigens. In both C57Bl/6 and F1 mice, HSV antigens were limited to anterior segment structures in the injected eye, whereas, in contrast to BALB/c mice, the contralateral retina appeared histologically normal and contained no viral antigens. The C57Bl/6 and F1 strains remained relatively resistant to retinal infection even if pretreated with up to 800 Rads of irradiation. The retinas of normal or sublethally irradiated C57Bl/6 and F1, but not BALB/c strains, were also resistant to intravitreal injection of HSV. These results suggest that resistance to HSV retinitis is a dominantly inherited trait, which depends only partly upon immunologic factors and may be heavily influenced by the inherent ability of host cells from different murine strains to support a productive viral infection.

Entities:  

Mesh:

Year:  1987        PMID: 3040616

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  In vivo expression of perforin by natural killer cells during a viral infection. Studies on uveitis produced by herpes simplex virus type I.

Authors:  L H Young; C S Foster; J D Young
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

2.  Mapping of genes involved in murine herpes simplex virus keratitis: identification of genes and their modifiers.

Authors:  Kazumi Norose; Akihiko Yano; Xiang-Ming Zhang; Elizabeth Blankenhorn; Ellen Heber-Katz
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Innate Mucosal Immune System Response of BALB/c vs C57BL/6 Mice to Injury in the Setting of Enteral and Parenteral Feeding.

Authors:  Rebecca A Busch; Mark A Jonker; Joseph F Pierre; Aaron F Heneghan; Kenneth A Kudsk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-11-17       Impact factor: 4.016

4.  Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring.

Authors:  H Ghiasi; S Cai; G C Perng; A B Nesburn; S L Wechsler
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

5.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections.

Authors:  K Geiger; E L Howes; N Sarvetnick
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Innate and adaptive immune responses to herpes simplex virus.

Authors:  Tracy Chew; Kathryne E Taylor; Karen L Mossman
Journal:  Viruses       Date:  2009-11-18       Impact factor: 5.048

8.  The recruitment of peripheral blood leukocytes to the brain is delayed in susceptible BALB/c compared to resistant C57BL/6 mice during herpes simplex virus encephalitis.

Authors:  Coraline Canivet; Olus Uyar; Chantal Rhéaume; Jocelyne Piret; Guy Boivin
Journal:  J Neurovirol       Date:  2019-02-13       Impact factor: 3.739

9.  Modulation of immune-associated surface markers and cytokine production by murine retinal glial cells.

Authors:  K M Drescher; J A Whittum-Hudson
Journal:  J Neuroimmunol       Date:  1996-01       Impact factor: 3.478

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.